ATEZOLIZUMAB

UNII:	52CMI0WC3Y
Formula:
Preferred Substance Name:	ATEZOLIZUMAB

1380723-44-3
0INE2SFD9E
AN ANTIBODY TO PROGRAMMED DEATH LIGAND 1 FOR CANCER THERAPY
ATEZOLIZUMAB [INN]
ATEZOLIZUMAB [JAN]
ATEZOLIZUMAB [MI]
ATEZOLIZUMAB [PURPLE BOOK CDER]
ATEZOLIZUMAB [USAN]
ATEZOLIZUMAB [WHO-DD]
ATEZOLIZUMAB-TQJC
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD274) (HUMAN MONOCLONAL MPDL3280A HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MPDL3280A .KAPPA.-CHAIN, DIMER
MPDL3280A
MPDL-3280A
RG7446
RG-7446
TECENTRIQ
TECENTRIQ HYBREZA COMPONENT ATEZOLIZUMAB

Common Chemistry
i
Inxight Drugs
i
DailyMed Regulated Products
i
GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ATEZOLIZUMAB

Synonyms and Mappings

Resources